Senior Director, Immunology S&E – Late-Stage Deals (Hybrid)

CSL; Glattbrugg; Hybrid; CHF 250,000 - 420,000; Full time

Job summary

CSL Behring is expanding its external innovation capability and seeks a Senior Director of Search & Evaluation to drive strategic sourcing and evaluation of late-stage Immunology assets. This role requires deep clinical expertise and strong engagement with external KOLs and investigators, with hybrid onsite work at our Zurich hub (3 days/week).

The position cannot be held remotely. As part of the Therapy Area Leadership Team, you will shape therapeutic strategy, coordinate cross-functional due

Qualifications

• 15+ years in biopharma with clinical development/external innovation or business development.
• Advanced degree (MD, PhD) or equivalent required.
• Deep Immunology clinical expertise and understanding of regulatory pathways.

Responsibilities

• Serve as the senior S&E leader within the Therapy Area Leadership Team, shaping strategy and portfolio planning.
• Lead proactive sourcing for Phase 2 to marketed assets aligned with TA strategy and unmet needs.
• Co-lead internal meetings focusing on evaluating and prioritizing New Product Opportunities in Immunology.
• Coordinate cross-functional due diligence for late-stage assets and support deal negotiations.
• Engage with external KOLs and investigators to validate asset potential and trial designs.
• Represent the TA externally, leading sourcing at conferences and building pharma/biotech networks.

Job description

CSL Behring is expanding its external innovation capability and seeks a Senior Director of Search & Evaluation to drive strategic sourcing and evaluation of late-stage Immunology assets. This role requires deep clinical expertise and strong engagement with external KOLs and investigators, with hybrid onsite work at our Zurich hub (3 days/week).

The position cannot be held remotely. As part of the Therapy Area Leadership Team, you will shape therapeutic strategy, coordinate cross-functional due